GlassScriptPhysician profile
Cathryn Hogan
NPI 1891299558
$4,144.44
in general payments reported to CMS, 2019-2025
21 companies · $47.20 in 2025
The $47.20 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $811 · 2022: $3,106 · 2023: $163 · 2024: $18.04 · 2025: $47.20.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $228.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $227.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,537.61 | 2021-2025 | Lithovue |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $474.05 | 2021-2023 | Relistor |
| Abbvie INC. | $261.40 | 2021-2025 | |
| Nevro Corp. | $174.92 | 2021 | |
| Stimwave Technologies Incorporated | $107.68 | 2022 | |
| Collegium Pharmaceutical, INC. | $90.55 | 2021-2023 | Belbuca |
| Lilly USA, LLC | $74.88 | 2021-2023 | Reyvow, Emgality |
| Grt US Holding, INC. | $51.41 | 2021 | |
| Channel Medsystems, INC. | $44.63 | 2023 | |
| Amgen INC. | $40.21 | 2022 | |
| Lundbeck LLC | $38.93 | 2022 | |
| Spr Therapeutics, INC | $36.87 | 2022 | |
| Virtus Pharmaceuticals LLC | $35.93 | 2021 | |
| Almatica Pharma LLC | $35.41 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $32.58 | 2022-2023 | Seglentis |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $24.14 | 2021 | |
| Scilex Pharmaceuticals INC. | $20.01 | 2021 | |
| Redhill Biopharma INC. | $19.35 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $15.41 | 2021 | |
| Allergan, INC. | $15.07 | 2021 | |
| Orthogenrx INC. | $13.40 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cathryn Hogan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.